Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Drugs|January 1, 1987
Diffusion of ofloxacin into human lung tissueL Couraud, J B Fourtillan, M C Saux, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteersB Lenfant, F Namour, C Logeais, et al.
Infection|January 1, 1986
[Diffusion of ofloxacin in human lung tissue]L Couraud, J B Fourtillan, M C Saux, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimensF Soriano, R Fernández-Roblas, R Calvo, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionF G Araujo, A A Khan, T L Slifer, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factorsP Bemer-Melchior, M E Juvin, S Tassin, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre studyC J Soussy, M Cluzel, M C Ploy, et al.
Pathologie-Biologie|May 1, 1985
[Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis]J P Stahl, J Croize, J P Bru, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenesK Nagai, T A Davies, L M Ednie, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 10, 2001
Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, GermanyC M Brandt, M Honscha, N D Truong, et al.
Pageof 12